Agrylin 0.5 mg Capsule

Description

Agrylin 0.5 mg Capsule contains Anagrelide, a medicine used to reduce high platelet counts in patients with essential thrombocythemia. It helps lower the risk of blood clots and related complications under medical supervision.

Benefits

• Effectively lowers elevated platelet levels

• Reduces risk of blood clots, stroke, and heart attack

• Helps relieve ET-related symptoms (headache, burning hands/feet)

• Oral capsule for convenient long-term treatment

Indications and Usage

Agrylin 0.5 mg Capsule is indicated for:

• Essential Thrombocythemia (ET)

• Other conditions involving abnormally high platelet counts (as prescribed)

Used to prevent clotting-related complications such as thrombosis and bleeding.

How it Works

Anagrelide reduces platelet counts by inhibiting megakaryocyte maturation in the bone marrow. This decreases platelet production and lowers the risk of dangerous clot formation.

Dosage & Administration

• Typical starting dose: 0.5 mg 2–4 times daily, or as prescribed

• Dose may be gradually adjusted based on platelet response

• Swallow capsules whole with water

• Do not skip, exceed, or stop doses without medical advice

• Regular platelet count and heart monitoring required

Use only under hematologist supervision.

Side Effects

Common side effects:

• Headache

• Palpitations

• Dizziness

• Diarrhea

• Nausea

• Fluid retention

Serious side effects (seek urgent care):

• Chest pain or irregular heartbeat

• Shortness of breath

• Severe bleeding or bruising

• Fainting

• Worsening heart disease

Warning and Precaution

• Not recommended during pregnancy or breastfeeding

• Use cautiously in patients with heart disease, arrhythmia, or liver/kidney impairment

• Report chest pain, fainting, rapid heartbeat, or severe bleeding immediately

• Avoid alcohol unless approved by the doctor

• Inform doctor about blood thinners or heart medications

• Not for self-treatment or OTC use